Skip to main content
Clinical Trials/TCTR20210825007
TCTR20210825007
Not yet recruiting
Phase 1

Safety and Efficacy of Chula High Flow Nasal Cannula

/A0 sites15 target enrollmentAugust 25, 2021

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Phase 1 Healthy group Phase 2 COVID-19 with respiratory failure
Sponsor
/A
Enrollment
15
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 25, 2021
End Date
September 24, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Phase 1: Healthy subjects (N\=5\)
  • Phase 2: COVID\-19 pneumonia with respiratory failure (PF ratio 150\-300 or SpO2 \<90\-94% while using conventional oxygen therapy) for at least 2 hours or met other criteria to use HFNC (N\=10\)

Exclusion Criteria

  • Phase 1: 1\. underlying significant cardiopulmonary disease
  • 2\. unable to communicate
  • Phase 2: 1\. signs of respiratory failure (RR\>40\) or use accessory muscles
  • 2\. met criteria for intubation including PF ratio\<50, unable to protect airway, mental status change, unstable hemodynamic, reduction in glasgow coma scale\<10

Outcomes

Primary Outcomes

Not specified

Similar Trials